Encuity Introduces Re-Branded SDI Health Studies

US market research and analytics provider Encuity Research has introduced a suite of seven re-branded syndicated studies, designed to provide insights to pharma and biotech firms about medical treatment and product promotion occurring at provider and consumer levels.

Encuity Research was formed earlier this year, by InVentiv Health's MR and analytics arm Campbell Alliance, following inVentiv Health's acquisition of two SDI Health promotional and medical audit businesses from healthcare research giant IMS Health.

The new 'Encuity Answer Suite' of studies is an extension of the audits previously offered by SDI Health, and features syndicated offerings such as TreatmentAnswers (formerly the Pysician Drug and Diagnosis Audit), and SampleAnswers (previously known as the Sample Distribution Audit).

Michael Turner (pictured), General Manager of Encuity Research, explains: 'Encuity Answer Suite audits have been refined for improved relevancy to customers; however, the scope of the audits remains unchanged. In fact, their history, starting as early as 1989, will remain available through Encuity's online access site, the Answer Generator.'

Web site: www.encuity.com .